Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ)
CNY 6.92
(2.52%)
CNY 6.92
(2.52%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 347.72 Million CNY | -19.26% |
| 2022 | 430.66 Million CNY | -0.49% |
| 2021 | 432.8 Million CNY | 8.69% |
| 2020 | 398.19 Million CNY | 1.03% |
| 2019 | 394.12 Million CNY | 0.29% |
| 2018 | 392.97 Million CNY | 14.56% |
| 2017 | 343.04 Million CNY | -0.63% |
| 2016 | 345.21 Million CNY | -1.11% |
| 2015 | 349.09 Million CNY | 1.31% |
| 2014 | 344.56 Million CNY | 165.15% |
| 2013 | 129.95 Million CNY | 148.15% |
| 2012 | 52.36 Million CNY | 28.26% |
| 2011 | 40.83 Million CNY | -0.52% |
| 2010 | 41.04 Million CNY | 12.43% |
| 2009 | 36.5 Million CNY | -7.54% |
| 2008 | 39.48 Million CNY | -3.04% |
| 2007 | 40.71 Million CNY | 5.53% |
| 2006 | 38.58 Million CNY | 29.86% |
| 2005 | 29.71 Million CNY | 91.94% |
| 2004 | 15.47 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 46.19 Million CNY | -8.27% |
| 2024 Q1 | 50.97 Million CNY | -43.82% |
| 2024 Q2 | 50.35 Million CNY | -1.22% |
| 2023 Q4 | 90.73 Million CNY | 6.43% |
| 2023 Q1 | 84.08 Million CNY | -41.22% |
| 2023 FY | 347.72 Million CNY | -19.26% |
| 2023 Q2 | 87.63 Million CNY | 4.22% |
| 2023 Q3 | 85.25 Million CNY | -2.72% |
| 2022 Q1 | 81.05 Million CNY | -35.01% |
| 2022 Q4 | 143.06 Million CNY | 25.28% |
| 2022 Q3 | 114.19 Million CNY | 23.67% |
| 2022 FY | 430.66 Million CNY | -0.49% |
| 2022 Q2 | 92.34 Million CNY | 13.92% |
| 2021 Q1 | 87.58 Million CNY | -35.66% |
| 2021 Q3 | 116.43 Million CNY | 11.88% |
| 2021 Q4 | 124.71 Million CNY | 7.11% |
| 2021 FY | 432.8 Million CNY | 8.69% |
| 2021 Q2 | 104.07 Million CNY | 18.83% |
| 2020 FY | 398.19 Million CNY | 1.03% |
| 2020 Q2 | 88.1 Million CNY | 49.41% |
| 2020 Q1 | 58.96 Million CNY | -54.65% |
| 2020 Q4 | 136.12 Million CNY | 18.38% |
| 2020 Q3 | 114.99 Million CNY | 30.52% |
| 2019 Q3 | 100.69 Million CNY | -0.12% |
| 2019 Q2 | 100.81 Million CNY | 61.08% |
| 2019 Q1 | 62.59 Million CNY | -60.47% |
| 2019 Q4 | 130.01 Million CNY | 29.12% |
| 2019 FY | 394.12 Million CNY | 0.29% |
| 2018 Q3 | 89.79 Million CNY | 2.91% |
| 2018 Q1 | 57.6 Million CNY | -55.66% |
| 2018 Q2 | 87.25 Million CNY | 51.48% |
| 2018 FY | 392.97 Million CNY | 14.56% |
| 2018 Q4 | 158.31 Million CNY | 76.31% |
| 2017 Q1 | 54.52 Million CNY | -61.0% |
| 2017 FY | 343.04 Million CNY | -0.63% |
| 2017 Q4 | 129.91 Million CNY | 65.67% |
| 2017 Q3 | 78.42 Million CNY | -2.21% |
| 2017 Q2 | 80.18 Million CNY | 47.08% |
| 2016 FY | 345.21 Million CNY | -1.11% |
| 2016 Q1 | 47.08 Million CNY | -62.56% |
| 2016 Q2 | 73.67 Million CNY | 56.47% |
| 2016 Q4 | 139.78 Million CNY | 65.09% |
| 2016 Q3 | 84.67 Million CNY | 14.92% |
| 2015 FY | 349.09 Million CNY | 1.31% |
| 2015 Q4 | 125.76 Million CNY | 71.8% |
| 2015 Q3 | 73.2 Million CNY | -15.95% |
| 2015 Q2 | 87.1 Million CNY | 38.2% |
| 2015 Q1 | 63.02 Million CNY | -44.86% |
| 2014 Q3 | 77.96 Million CNY | -5.88% |
| 2014 Q4 | 114.29 Million CNY | 46.61% |
| 2014 Q1 | 69.48 Million CNY | -16.35% |
| 2014 FY | 344.56 Million CNY | 165.15% |
| 2014 Q2 | 82.82 Million CNY | 19.2% |
| 2013 Q3 | 16.24 Million CNY | 5.16% |
| 2013 Q4 | 83.06 Million CNY | 411.35% |
| 2013 FY | 129.95 Million CNY | 148.15% |
| 2013 Q1 | 15.19 Million CNY | -9.87% |
| 2013 Q2 | 15.44 Million CNY | 1.67% |
| 2012 Q4 | 16.85 Million CNY | 23.99% |
| 2012 Q1 | 7.73 Million CNY | -49.44% |
| 2012 Q3 | 13.59 Million CNY | -4.17% |
| 2012 FY | 52.36 Million CNY | 28.26% |
| 2012 Q2 | 14.18 Million CNY | 83.51% |
| 2011 Q2 | 5.97 Million CNY | -48.55% |
| 2011 Q4 | 15.28 Million CNY | 92.44% |
| 2011 Q3 | 7.94 Million CNY | 32.9% |
| 2011 Q1 | 11.61 Million CNY | -7.01% |
| 2011 FY | 40.83 Million CNY | -0.52% |
| 2010 Q2 | 12.9 Million CNY | 50.71% |
| 2010 FY | 41.04 Million CNY | 12.43% |
| 2010 Q3 | 7.07 Million CNY | -45.19% |
| 2010 Q1 | 8.56 Million CNY | -20.75% |
| 2010 Q4 | 12.49 Million CNY | 76.58% |
| 2009 Q2 | 8.93 Million CNY | 6.95% |
| 2009 Q3 | 8.4 Million CNY | -6.01% |
| 2009 Q4 | 10.8 Million CNY | 28.65% |
| 2009 FY | 36.5 Million CNY | -7.54% |
| 2009 Q1 | 8.35 Million CNY | -31.04% |
| 2008 Q4 | 12.11 Million CNY | 21.95% |
| 2008 Q2 | 8.56 Million CNY | -3.36% |
| 2008 Q1 | 8.86 Million CNY | -34.95% |
| 2008 FY | 39.48 Million CNY | -3.04% |
| 2008 Q3 | 9.93 Million CNY | 16.05% |
| 2007 FY | 40.71 Million CNY | 5.53% |
| 2007 Q2 | 10.07 Million CNY | 41.99% |
| 2007 Q1 | 7.09 Million CNY | -52.63% |
| 2007 Q3 | 9.91 Million CNY | -1.63% |
| 2007 Q4 | 13.62 Million CNY | 37.39% |
| 2006 Q3 | 9.29 Million CNY | 0.0% |
| 2006 Q4 | 14.98 Million CNY | 61.28% |
| 2006 FY | 38.58 Million CNY | 29.86% |
| 2005 FY | 29.71 Million CNY | 91.94% |
| 2004 FY | 15.47 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 2.18 Billion CNY | 84.122% |
| Zhejiang Zhenyuan Share Co., Ltd. | 762.64 Million CNY | 54.406% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 458.96 Million CNY | 24.239% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 187.93 Million CNY | -85.022% |
| Yifan Pharmaceutical Co., Ltd. | 1.83 Billion CNY | 81.008% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 10.7 Billion CNY | 96.751% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 620.91 Million CNY | 43.999% |
| Boai NKY Medical Holdings Ltd. | 894.38 Million CNY | 61.122% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 808 Million CNY | 56.965% |